A Registry to Evaluate Patterns of Care Associated With the Use of Corus CAD (or ASGES) in Primary Care Settings
NCT ID: NCT01677156
Last Updated: 2019-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
713 participants
OBSERVATIONAL
2012-08-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of a Novel Gene Expression Test (ASGES or Corus CAD) for Diagnosis of Obstructive Coronary Artery Disease
NCT01557855
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
NCT01594411
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
NCT01117506
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree
NCT00500617
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
NCT02223286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Receiving Corus CAD (ASGES)
Patients receiving Corus CAD (ASGES) to aid in the diagnosis of obstructive CAD
CORUS CAD (ASGES)
Age/Sex/Gene Expression Score - ASGES
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CORUS CAD (ASGES)
Age/Sex/Gene Expression Score - ASGES
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Receiving Corus CAD (ASGES) to aid in the diagnosis of obstructive CAD
3. Age \>= 18 years
4. Willing and able to provide written informed consent
Exclusion Criteria
2. Current MI or acute coronary syndrome
3. Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms
4. Known/documented CAD
5. Diabetes Mellitus
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioDx
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Zapien, MS
Role: STUDY_DIRECTOR
CardioDx, Inc.
Mark Monane, MD
Role: PRINCIPAL_INVESTIGATOR
CardioDx, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Warner Family Practice
Chandler, Arizona, United States
Synergy Health
Hiawassee, Georgia, United States
John's Creek Primary Care
Suwanee, Georgia, United States
Paul McLaughlin, MD - Family Practice
Mount Sterling, Kentucky, United States
KD Health and Wellness Center
Simmesport, Louisiana, United States
Doctors for Health
Omaha, Nebraska, United States
TIMA Wellness
Greensboro, North Carolina, United States
Dayton Internal Medicine
Dayton, Ohio, United States
Northside Medical Center
Youngstown, Ohio, United States
Bells Medical Clinic
Bells, Texas, United States
Family Care Clinic
Bonham, Texas, United States
Aldrich Internal Medicine
Dallas, Texas, United States
Texas Familicare
Hurst, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ladapo JA, Budoff M, Sharp D, Zapien M, Huang L, Maniet B, Herman L, Monane M. Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease. Am J Med. 2017 Apr;130(4):482.e11-482.e17. doi: 10.1016/j.amjmed.2016.11.021. Epub 2016 Dec 16.
Ladapo JA, Budoff MJ, Sharp D, Kuo JZ, Huang L, Maniet B, Herman L, Monane M. Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery Disease. J Am Geriatr Soc. 2018 Feb;66(2):309-315. doi: 10.1111/jgs.15215. Epub 2017 Dec 6.
Related Links
Access external resources that provide additional context or updates about the study.
Am J Med. 2017 Apr;130(4):482.e11-482.e17. doi: 10.1016/j.amjmed.2016.11.021. Epub 2016 Dec 16.
The American Journal of Medicine (PRESET study)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRESET
Identifier Type: OTHER
Identifier Source: secondary_id
CDX_000015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.